Skip to main content Skip to main navigation menu Skip to site footer
DTI logo
  • About
    • About the Journal
    • The Publisher
    • Publication ethics
    • Abstracting and indexing
    • Privacy Statement
    • Contact
  • Editorial team
  • Policies
    • Open Access policy
    • Editorial policies
    • Self archiving and sharing policy
    • Commercial policies
    • Waiver and discount policy
    • Privacy policy
  • Guidelines
    • Guidelines for Authors
    • Guidelines for Reviewers
    • Artwork guidelines
    • Publication fees
    • Content type
  • Archives
  • Latest articles
  • Open call for papers
Search
  • Register
  • Login
  • Submit now
  1. Home /
  2. Archives /
  3. Vol. 10 No. Suppl. 1 (2016): Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis /
  4. Editorial

Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis

Authors

  •      

DOI:

https://doi.org/10.33393/dti.2016.1424

Abstract

No Abstract

Downloads

  • PDF

How to Cite

 , . (2016). Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis. Drug Target Insights, 10(Suppl. 1). https://doi.org/10.33393/dti.2016.1424
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 10 No. Suppl. 1 (2016): Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis

Section

Editorial

Metrics

Crossref
Scopus
Google Scholar
Europe PMC

Statistics

  • Abstract views - 1714 times
  • PDF downloads - 469 times

Sign up

Browse

  • Sections
    • Antimicrobial Resistance
    • Phytotherapeutics and natural products
    • Miscellaneous

banners150

3.5
2024CiteScore
 
 
69th percentile
Powered by  Scopus

SCImago Journal & Country Rank

 

Completed peer reviews since:
June 5, 2020

Most read in the last 30 days
  • Antioxidant potential of a new macrocyclic bisbibenzyl and other compounds from Combretum molle: in vitro and docking analyses
    308
  • Licorice as a herbal extract in periodontal therapy
    253
  • Management of urinary tract infections in the era of antimicrobial resistance
    238
  • P-glycoprotein Inhibition for Optimal Drug Delivery
    221
  • Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series
    198

Drug Target Insights | eISSN 1177-3928

AboutScience Srl  | Piazza Duca d’Aosta, 12 | 20124 Milano (MI) - Italy
Tel +39 02 2772 9949 | www.aboutscience.eu | VAT IT10418650965 | Privacy policy | Cookie Policy

 Linkedin

Platform and workflow OJS/PKP | Hosting Archimede Informatica | Customizations e-Danex Digital Solutions

More information about the publishing system, Platform and Workflow by OJS/PKP.